Pfizer to expand consumer healthcare business with Ferrosan acquisition
This article was originally published in Scrip
Executive Summary
Having just announced the decision to shut a large R&D facility in the UK, Pfizer said it intends to acquire a Danish consumer healthcare firm. Ferrosan, which markets dietary supplements and lifestyle products, is currently owned by the private equity investor Altor.